According to Zhitong Finance App, Jingyou Pharmaceutical (00858.HK) announced that on October 30, 2026, the company plans to place up to 580 million shares to be placed, accounting for 20% of the company's current issued share capital at the date of this announcement; and about 16.67% of the company's issued share capital expanded by issuing and placing shares. The placement price of HK$0.052 per share is approximately 1.96% higher than the closing price of HK$0.051 per share on October 30. Assuming that the highest number of shares to be placed under the placement agreement, the total proceeds from the placement will be approximately HK$30.2 million, while the net proceeds will be approximately HK$29.4 million. It is anticipated that (a) approximately HK$9.8 million (accounting for approximately 33.33% of the highest net income) will be used to expand the Group's electronic module and related product trading business; (b) approximately HK$19.6 million (accounting for about 66.67% of the highest net income) will be used by the Group to support the commencement of its electronic module and related product manufacturing, sales and research and development business.

According to Zhitong Finance App, Jingyou Pharmaceutical (00858.HK) announced that on October 30, 2026, the company plans to place up to 580 million shares to be placed, accounting for 20% of the company's current issued share capital at the date of this announcement; and about 16.67% of the company's issued share capital expanded by issuing and placing shares. The placement price of HK$0.052 per share is approximately 1.96% higher than the closing price of HK$0.051 per share on October 30. Assuming that the highest number of shares to be placed under the placement agreement, the total proceeds from the placement will be approximately HK$30.2 million, while the net proceeds will be approximately HK$29.4 million. It is anticipated that (a) approximately HK$9.8 million (accounting for approximately 33.33% of the highest net income) will be used to expand the Group's electronic module and related product trading business; (b) approximately HK$19.6 million (accounting for about 66.67% of the highest net income) will be used by the Group to support the commencement of its electronic module and related product manufacturing, sales and research and development business.